Panc 03.27 Cells

Panc 03.27 (PL11) is a human pancreatic adenocarcinoma cell line derived from a primary tumor. This cell line is a valuable resource for studying the molecular and genetic alterations characteristic of pancreatic cancer, a disease with notoriously poor prognosis and limited treatment options. Panc 03.27 is particularly utilized in research focused on genomic instability, allelic loss, and tumor suppressor gene alterations.

This cell line is characterized by significant chromosomal abnormalities, including regions of allelic loss and homozygous deletions, as revealed through high-resolution SNP arrays. Such deletions frequently implicate loci associated with tumor suppressor genes, providing insight into the genetic mechanisms driving pancreatic tumorigenesis. Panc 03.27 has been instrumental in understanding the impact of chromosomal instability patterns on the progression and heterogeneity of pancreatic cancers, highlighting genomic “”holes”” or regions prone to homozygous deletions.

Panc 03.27 is used in preclinical research to evaluate novel therapeutic approaches, including those targeting genetic vulnerabilities specific to pancreatic cancer. Its genomic profile makes it a key model for studies of somatic mutations, gene loss, and tumor progression, helping to identify potential biomarkers and treatment targets. The cell line’s ability to provide consistent and reproducible results ensures its ongoing importance in pancreatic cancer research and drug development.